Contrast induced nephropathy: Updated ESUR Contrast Media Safety Committee guidelines

European Radiology

Volumn 21, Issue 12, 2011, Pages 2527-2541

  Stacul, Fulvio ^a   Van Der Molen, Aart J ^b   Reimer, Peter ^c   Webb, Judith A W ^d   Thomsen, Henrik S ^e   Morcos, Sameh K ^f   Almén, Torsten ^g   Aspelin, Peter ^h   Bellin, Marie France ⁱ   Clement, Olivier ^j   Heinz Peer, Gertraud ^k  

^a MAGGIORE HOSPITAL   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f NORTHERN GENERAL HOSPITAL   (United Kingdom)

^g Northern General Hospital ^*  (Sweden)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ BICÊTRE HOSPITAL   (France)

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^k UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

Contrast medium induced nephropathy; Gadolinium based contrast media; Iodine based contrast media; Metformin; Renal failure

Indexed keywords

ACETYLCYSTEINE; C REACTIVE PROTEIN; GADOLINIUM; METFORMIN;

AGE; ARTICLE; BRONCHOSPASM; COCHRANE LIBRARY; CONTRAST INDUCED NEPHROPATHY; DEHYDRATION; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; DRUG WITHDRAWAL; EMBASE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDRATION; HYPOTENSION; INCIDENCE; MEDLINE; META ANALYSIS (TOPIC); PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 83555173218     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2225-0     Document Type: Article

References (159)

1. SK Morcos HS Thomsen JAW Webb, et al. 1999 Contrast-media-induced nephrotoxicity: a consensus report Eur Radiol 9 1602 1613 10525875 1:STN:280:DyaK1Mvlslanuw%3D%3D
2. HS Thomsen SK Morcos ESUR Contrast Media Safety Committee 1999 Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media Eur Radiol 9 738 740 10354898 1:STN:280:DyaK1M3otlehtw%3D%3D
3. Renal adverse reactions to iodinated contrast media (2008) Contrast media safety guidelines of the Contrast Media Safety Committee of the European Society of Urogenital Radiology, version 7.0. Available at: http://www.esur.org/ Contrast-media.51.0.html#c269 Accessed 6 June 2011
4. PA McCullough F Stacul C Davidson, et al. 2006 Overview Am J Cardiol 98 2K 4K
5. BA Molitoris A Levin DG Warnock, et al. 2007 Improving outcomes from acute kidney injury J Am Soc Nephrol 18 1992 1994 17596636 1:CAS:528: DC%2BD2sXotlWntLk%3D (Pubitemid 47041061)
6. BA Molitoris A Levin DG Warnock, et al. 2007 Improving outcomes of acute kidney injury: report of an initiative Nat Clin Pract Nephrol 3 439 442 17653122 (Pubitemid 47123586)
7. RL Mehta JA Kellum SV Shah, et al. 2007 Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 R31 17331245
8. SD Weisbord H Chen RA Stone, et al. 2006 Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography J Am Soc Nephrol 17 2871 2877 16928802 1:CAS:528: DC%2BD28XhtFWksb%2FN (Pubitemid 44484677)
9. RJ Solomon R Mehran MK Natarajan, et al. 2009 Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 4 1162 1169 19556381
10. SS Waikar JV Bonventre 2009 Creatinine kinetics and the definition of acute kidney injury J Am Soc Nephrol 20 672 679 19244578 1:CAS:528: DC%2BD1MXktVemtrs%3D
11. HS Thomsen SK Morcos 2009 Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT-a pooled analysis of two randomized trials Eur Radiol 19 891 897 19002467
12. D Reddan M Laville VD Garovic 2009 Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol 22 333 351 19557710 1:CAS:528:DC%2BD1MXhs1WitbjL
13. O Toprak 2007 What is the best definition of contrast-induced nephropathy? Ren Fail 29 387 388 17497458 (Pubitemid 46752357)
14. CJ Davidson M Hlatky KG Morrris, et al. 1989 Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial Ann Intern Med 110 119 124 2909204 1:STN:280:DyaL1M%2FnsFCksg%3D%3D (Pubitemid 19033197)
15. PA McCullough KR Sandberg 2003 Epidemiology of contrast-induced nephropathy Rev Cardiovasc Med 4 53 59
16. JH Newhouse D Kho QA Rao J Starren 2008 Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity AJR Am J Roentgenol 191 376 382 18647905
17. RJ Bruce A Djamali K Shinki, et al. 2009 Background fluctuation of kidney function versus contrast-induced nephrotoxicity AJR Am J Roentgenol 192 711 718 19234268
18. O Toprak 2007 Risk markers for contrast-induced nephropathy Am J Med Sci 334 283 290 18030185 (Pubitemid 351339287)
19. HS Thomsen SK Morcos Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) 2005 In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15 749 754 15627181
20. BA Bartholomew KJ Harjai S Dukkipati, et al. 2004 Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification Am J Cardiol 93 1515 1519 15194023 (Pubitemid 38749208)
21. JR Brown JT DeVries WD Piper, et al. 2008 Serious renal dysfunction after percutaneous coronary interventions can be predicted Am Heart J 155 260 266 18215595
22. PA McCullough R Wolyn LL Rocher, et al. 1997 Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 368 375 9375704 1:STN:280:DyaK1c%2FktFGmsA%3D%3D (Pubitemid 27506242)
23. R Mehran ED Aymong E Nikolsky, et al. 2004 A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 1393 1399 15464318 (Pubitemid 39303939)
24. CS Rihal SC Textor DE Grill, et al. 2002 Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2259 2264 12010907 (Pubitemid 34535335)
25. G Dangas I Iakovou E Nikolsky, et al. 2005 Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables Am J Cardiol 95 13 19 15619387 (Pubitemid 40051105)
26. GJ Schwartz GB Haycock CM Edelmann A Spitzer 1976 A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine Pediatrics 58 259 263 951142 1:CAS:528:DyaE28XlsFKisr4%3D
27. AS Levey LA Stevens CH Schmid, et al. 2009 A new equation to estimate glomerular filtration rate Ann Intern Med 150 604 612 19414839
28. RJ Glassock C Winearls 2008 The global burden of chronic kidney disease: how valid are the estimates? Nephron Clin Pract 110 c39 c47 18689986
29. P Delanaye EP Cohen 2008 Formula-based estimates of the GFR: equations variable and uncertain Nephron Clin Pract 110 c48 c54 18708727 1:CAS:528:DC%2BD1cXhtFCis7vO
30. PS Parfrey SM Griffiths BJ Barrett, et al. 1989 Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study New Engl J Med 320 143 149 2643041 1:STN:280:DyaL1M%2FpslWjtQ%3D%3D (Pubitemid 19033091)
31. L Gruberg GS Mintz R Mehran, et al. 2000 The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency J Am Coll Cardiol 36 1542 1548 11079656 1:STN:280:DC%2BD3M%2FnsVGmtQ%3D%3D
32. G Marenzi G Lauri E Assanelli, et al. 2004 Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J Am Coll Cardiol 44 1780 1785 15519007 (Pubitemid 39424075)
33. E Alamartine M Phayphet D Thibaudin, et al. 2003 Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations Eur J Intern Med 14 426 431 14614975 (Pubitemid 37406661)
34. SK Morcos 2005 Prevention of contrast media induced nephrotoxicity after angiographic procedures J Vasc Interv Radiol 16 13 23 15640403 (Pubitemid 40096499)
35. PA McCullough SS Soman 2005 Contrast-induced nephropathy Crit Care Clin 21 261 280 15781162 (Pubitemid 40386754)
36. E Nikolsky R Mehran Z Lasic, et al. 2005 Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions Kidney Int 67 706 713 15673320 (Pubitemid 40139864)
37. CS McCarthy JA Becker 1992 Multiple myeloma and contrast media Radiology 183 519 521 1561361 1:STN:280:DyaK383itV2ruw%3D%3D
38. L Preda A Agazzi S Raimondi, et al. 2011 Effect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathies Eur Radiol 21 63 69 20680288
39. RW Katzberg R Lamba 2009 Contrast-induced nephropathy after intravenous administration: fact or fiction? Radiol Clin North Am 47 789 800 19744594
40. SD Weisbord MK Mor AL Resnick, et al. 2008 Incidence and outcomes of contrast-induced AKI following computed tomography Clin J Am Soc Nephrol 3 1274 1281 18463172
41. SM Kim R Cha JP Lee, et al. 2010 Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report Am J Kidney Dis 55 1018 1025 20097462
42. C Bauer ML Melamed TH Hostetter 2008 Staging of chronic kidney disease: time for a course correction J Am Soc Nephrol 19 844 846 18385419
43. RJ Glassock 2009 Estimated glomerular filtration rate: time for a performance review? Kidney Int 75 1001 1003 19404279
44. N Abutaleb 2007 Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components Nephrol Dial Transplant 22 2728 2729 17567651 (Pubitemid 47365548)
45. BJ Barrett EJ Carlisle 1993 Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 171 178 8511292 1:STN:280:DyaK3s3ovVylug%3D%3D (Pubitemid 23183119)
46. P Aspelin P Aubry SG Fransson, et al. 2003 Nephrotoxic effects in high-risk patients undergoing angiography New Engl J Med 348 491 499 12571256 1:CAS:528:DC%2BD3sXovVKmsA%3D%3D (Pubitemid 36159884)
47. SH Jo TJ Youn BK Koo, et al. 2006 Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial J Am Coll Cardiol 48 924 930 16949481 1:CAS:528:DC%2BD28XpsVWmtb0%3D
48. B Nie WJ Cheng YF Li, et al. 2008 A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention Catheter Cardiovasc Interv 72 958 965 19021282
49. MR Rudnick C Davidson W Laskey, et al. 2008 Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial Am Heart J 156 776 782 18946896 1:CAS:528:DC%2BD1cXhtFOgt73M
50. RJ Solomon MK Natarajan S Doucet, et al. 2007 Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease Circulation 115 3189 3196 17562951 (Pubitemid 47012233)
51. R Wessely T Koppara C Bradaric, et al. 2009 Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention Circ Cardiovasc Interv 2 430 437 20031753
52. W Laskey P Aspelin C Davidson, et al. 2009 Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures Am Heart J 158 822 828 19853704 1:CAS:528:DC%2BD1MXhtlSqsrjE
53. C Briguori A Colombo F Airoldi, et al. 2005 Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine Kidney Int 68 2250 2255 16221226 1:CAS:528:DC%2BD2MXht1SgtbfI (Pubitemid 43117801)
54. N Chalmers RW Jackson 1999 Comparison of iodixanol and iohexol in renal impairment Br J Radiol 72 701 703 10624328 1:CAS:528:DyaK1MXltlGitrY%3D (Pubitemid 29355616)
55. KJ Hardiek RE Katholi RS Robbs CE Katholi 2008 Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography J Diabetes Complications 22 171 177 18413220 (Pubitemid 351552047)
56. CP Juergens JP Winter P Nguyen-Do, et al. 2009 Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial Intern Med J 39 25 31 18771430 1:CAS:528:DC%2BD1MXltFygsbs%3D
57. R Mehran E Nikolsky AJ Kirtane, et al. 2009 Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study JACC Cardiovasc Interv 2 415 421 19463464
58. SA Nguyen P Suranyi JG Ravenel, et al. 2008 Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function Radiology 248 97 105 18483232
59. HS Thomsen SK Morcos CM Erley, et al. 2008 The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography Invest Radiol 43 170 178 18301313 1:CAS:528:DC%2BD1cXisVWht7w%3D (Pubitemid 351643143)
60. BJ Barrett RW Katzberg HS Thomsen, et al. 2006 Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed-tomography: a double-blind comparison of iodixanol and iopamidol Invest Radiol 41 815 821 17035872 1:CAS:528:DC%2BD28XhtVKrt7jP (Pubitemid 44564026)
61. M Carraro F Malalan R Antonione, et al. 1998 Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind randomized clinical trial Eur Radiol 8 144 147 9442148 1:STN:280:DyaK1c7gs1altw%3D%3D (Pubitemid 128545052)
62. MJ Kuhn N Chen DV Sahani, et al. 2008 The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low or isoosmolar contrast agent exposure AJR Am J Roentgenol 191 151 157 18562739 (Pubitemid 351955220)
63. MC Heinrich L Häberle V Müller, et al. 2009 Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials Radiology 250 68 86 19092091
64. M Reed P Meier UU Tamhane, et al. 2009 The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials JACC Cardiovasc Interv 2 645 654 19628188
65. PA McCullough ME Bertrand JA Brinker F Stacul 2006 A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media J Am Coll Cardiol 48 692 699 16904536 1:CAS:528:DC%2BD28XotFWksLY%3D (Pubitemid 44175706)
66. WK Laskey C Jenkins F Selzer, et al. 2007 Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention J Am Coll Cardiol 50 584 590 17692741 1:CAS:528:DC%2BD2sXovFyntr4%3D (Pubitemid 47199002)
67. U Nyman J Biörk P Aspelin G Marenzi 2008 Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention Acta Radiol 49 658 667 18568558 1:STN:280:DC%2BD1cvgtVOksg%3D%3D
68. CL Manske JM Sprafka JT Strony Y Wang 1990 Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography Am J Med 89 615 620 2239981 1:STN:280:DyaK3M%2FltFGqsA%3D%3D (Pubitemid 20384319)
69. JH Ellis RH Cohan 2009 Prevention of contrast induced nephropathy: an overview Radiol Clin N Am 47 801 811 19744595
70. F Stacul A Adam CR Becker, et al. 2006 Strategies to reduce the risk of contrast-induced nephropathy Am J Cardiol 98 59K 77K 16949381 1:CAS:528:DC%2BD28XhtVyqurfN
71. HS Trivedi H Moore S Nasr, et al. 2003 A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity Nephron Clin Pract 93 C29 C34 12411756 1:CAS:528: DC%2BD38Xotl2ktrc%3D
72. B Dussol S Morange A Loundoun, et al. 2006 A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients Nephrol Dial Transplant 21 2120 2126 16611682 1:CAS:528:DC%2BD28Xotl2ktLc%3D (Pubitemid 44295036)
73. AJ Taylor D Hotchkiss RW Morse J McCabe 1998 PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction Chest 114 1570 1574 9872190 1:STN:280:DyaK1M%2FoslWqtw%3D%3D (Pubitemid 128487477)
74. C Mueller G Buerkle HJ Buettner, et al. 2002 Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty Arch Intern Med 162 329 336 11822926 1:CAS:528:DC%2BD38XitVGgu74%3D (Pubitemid 34127411)
75. BD Bader ED Berger MB Heede, et al. 2004 What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62 1 7 15267006 1:STN:280:DC%2BD2czmtl2ktA%3D%3D (Pubitemid 38979102)
76. RA Krasuski BM Beard JD Geoghagan, et al. 2003 Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study J Invasive Cardiol 15 699 702 14660821 (Pubitemid 37549287)
77. M Joannidis M Schmid CJ Wiedermann 2008 Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis Wien Klin Wochenschr 120 742 748 19122985 1:CAS:528:DC%2BD1MXjvFehtA%3D%3D
78. GJ Merten WP Burgess LV Gray, et al. 2004 Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 2328 2334 15150204 1:CAS:528:DC%2BD2cXktF2qu7k%3D (Pubitemid 38656299)
79. SS Brar S Hiremath G Dangas, et al. 2009 Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis Clin J Am Soc Nephrol 4 1584 1592 19713291 1:CAS:528: DC%2BD1MXhtlGgur%2FK
80. SE Hogan P L'allier S Chetcuti, et al. 2008 Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis Am Heart J 156 414 421 18760120 1:CAS:528:DC%2BD1cXhtVKmu7nJ
81. P Meier DT Ko A Tamura, et al. 2009 Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis BMC Med 7 23 19439062
82. SD Navaneethan S Singh S Appasamy, et al. 2009 Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Kidney Dis 53 617 627 19027212 1:CAS:528:DC%2BD1MXnslKrsbw%3D
83. SD Weisbord PM Palevsky 2008 Prevention of contrast-induced nephropathy with volume expansion Clin J Am Soc Nephrol 3 273 280 17989201 1:CAS:528:DC%2BD1cXhs1eitbg%3D
84. GG Biondi-Zoccai M Lotrionte A Abbate, et al. 2006 Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study BMJ 332 202 209 16415336
85. H Trivedi R Nadella A Szabo 2010 Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials Clin Nephrol 74 288 296 20875381 1:CAS:528:DC%2BC3cXhsFWls7bE
86. A Tamura Y Goto K Miyamoto, et al. 2009 Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure Am J Cardiol 104 921 925 19766757 1:CAS:528:DC%2BD1MXhtFKnsbbF
87. C Briguori A Colombo F Airoldi, et al. 2004 N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity J Am Coll Cardiol 44 762 765 15312855 1:CAS:528:DC%2BD2cXmslegu7w%3D (Pubitemid 39099569)
88. SR Majumdar CM Kjellstrand WJ Tymchak, et al. 2009 Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial Am J Kidney Dis 54 602 609 19535188 1:CAS:528: DC%2BD1MXhtlCgs7rI
89. TM Ng SW Shurmur M SIlver, et al. 2006 Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN) Int J Cardiol 109 322 328 16039733
90. GW Stone PA McCullough JA Tumlin, et al. 2003 Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial JAMA 290 2284 2291 14600187 1:CAS:528:DC%2BD3sXovVCjs7w%3D (Pubitemid 37430561)
91. N Attallah L Yassine J Musial, et al. 2004 The potential role of statins in contrast nephropathy Clin Nephrol 62 273 278 15524057 1:CAS:528: DC%2BD2cXptFOhtbc%3D (Pubitemid 39386803)
92. A Boscheri C Weinbrenner B Botzek, et al. 2007 Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction Clin Nephrol 68 279 286 18044259 1:CAS:528:DC%2BD2sXhsVGju7fK (Pubitemid 350047760)
93. C Briguori F Airoldi D D'Andrea, et al. 2007 Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies Circulation 115 1211 1217 17309916 1:CAS:528:DC%2BD2sXisVGjurs%3D (Pubitemid 46594764)
94. JH Ix CE McCulloch GM Chertow 2004 Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis Nephrol Dial Transplant 19 2747 2753 15328384 1:CAS:528:DC%2BD2cXovVOitrY%3D (Pubitemid 39480968)
95. W Huber F Eckel M Hennig, et al. 2006 Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study Radiology 239 793 804 16714461 (Pubitemid 43830615)
96. SH Jo BK Koo JS Park, et al. 2008 Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study Am Heart J 155 499.e1 499.e8
97. AM Kelly B Dwamena P Cronin, et al. 2008 Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 284 294 18283206 (Pubitemid 351665489)
98. S Khanal N Attallah DE Smith, et al. 2005 Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions Am J Med 118 843 849 16084176 1:CAS:528:DC%2BD2MXntVeitb0%3D (Pubitemid 41097461)
99. G Patti A Nusca M Chello, et al. 2008 Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention Am J Cardiol 101 279 285 18237585 1:CAS:528:DC%2BD1cXhsVSms78%3D (Pubitemid 351162953)
100. K Spargias E Adreanides E Demerouti, et al. 2009 Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Circulation 120 1793 1799 19841299 1:CAS:528:DC%2BD1MXhtlensr%2FL
101. K Spargias E Alexopoulos S Kyrzopoulos, et al. 2004 Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Circulation 110 2837 2842 15492300 1:CAS:528:DC%2BD2cXptVejsrY%3D (Pubitemid 39473606)
102. M Tepel M van der Giet C Schwarzfeld, et al. 2000 Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine New Engl J Med 343 180 184 10900277 1:CAS:528: DC%2BD3cXlsF2jsrs%3D (Pubitemid 30489215)
103. AD Azmus C Gottschall A Manica, et al. 2005 Effectiveness of acetylcysteine in prevention of contrast nephropathy J Invasive Cardiol 17 80 84 15687530 (Pubitemid 41741751)
104. C Briguori F Manganelli P Scarpato, et al. 2002 Acetylcysteine and contrast agent-associated nephrotoxicity J Am Coll Cardiol 40 298 303 12106935 1:CAS:528:DC%2BD38XmtVSksr0%3D (Pubitemid 34756291)
105. C Briguori A Colombo A Violante, et al. 2004 Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity Eur Heart J 25 206 211 14972420 1:CAS:528:DC%2BD2cXht1yhs7o%3D (Pubitemid 38235156)
106. J Kay WH Chow TM Chan, et al. 2003 Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289 553 558 12578487 1:CAS:528:DC%2BD3sXptVansw%3D%3D (Pubitemid 37428626)
107. G Marenzi E Assanelli I Marana, et al. 2006 N-acetylcysteine and contrast-induced nephropathy in primary angioplasty New Engl J Med 354 2773 2782 16807414 1:CAS:528:DC%2BD28XmsVKrur0%3D (Pubitemid 43974195)
108. JG Webb GE Pate KH Humphries, et al. 2004 A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect Am Heart J 148 422 429 15389228 1:CAS:528:DC%2BD2cXnvVOju7s%3D (Pubitemid 39265114)
109. H Trivedi S Daram A Szabo, et al. 2009 High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy Am J Med 122 874.e9 874.e15
110. S Fishbane 2008 N-acetylcysteine in the prevention of contrast-induced nephropathy Clin J Am Soc Nephrol 3 281 287 18003766 1:CAS:528: DC%2BD1cXhs1eitbk%3D
111. DA Gonzales KJ Norsworthy SJ Kern, et al. 2007 A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity BMC Med 5 32 18001477
112. N Pannu N Wiebe M Tonelli 2006 Prophylaxis strategies for contrast-induced nephropathy JAMA 295 2765 2779 16788132 1:CAS:528: DC%2BD28XmtFOlurw%3D
113. R Sinert CI Doty 2007 Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department Ann Emerg Med 50 335 345 17512638
114. A Zagler M Azadpour C Mercado CH Hennekens 2006 N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials Am Heart J 151 140 145 16368307 1:CAS:528:DC%2BD2MXhtlGisLjK (Pubitemid 41815344)
115. SM Bagshaw FA McAlister BJ Manns WA Ghali 2006 Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence Arch Intern Med 166 161 166 16432083 1:CAS:528: DC%2BD28XhtFagtLs%3D (Pubitemid 43144938)
116. JT Van Praet AS De Vriese 2007 Prevention of contrast-induced nephropathy: a critical review Curr Opin Nephrol Hypertens 16 336 347 17565276 (Pubitemid 46944332)
117. PT Vaitkus C Brar 2007 N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses Am Heart J 153 275 280 17239689 1:CAS:528:DC%2BD2sXntlGqug%3D%3D (Pubitemid 46096863)
118. U Hoffmann M Fischereder B Krueger, et al. 2004 The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable J Am Soc Nephrol 15 407 410 14747387 1:CAS:528: DC%2BD2cXhtV2itb0%3D (Pubitemid 38140781)
119. PA Poletti P Saudan A Platon, et al. 2007 I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity AJR Am J Roentgenol 189 687 692 17715118 (Pubitemid 47328553)
120. M Haase A Haase-Fielitz S Ratnaike, et al. 2008 N-Acetylcysteine does not artifactually lower plasma creatinine concentration Nephrol Dial Transplant 23 1581 1587 18202091 1:CAS:528:DC%2BD1cXkvF2gtrw%3D (Pubitemid 351767737)
121. SK Morcos HS Thomsen JA Webb, et al. 2002 Dialysis and contrast media Eur Radiol 12 3026 3030 12439587 (Pubitemid 36940429)
122. G Marenzi G Lauri J Campodonico, et al. 2006 Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients Am J Med 119 155 162 16443418 (Pubitemid 43151482)
123. G Marenzi I Marana G Lauri, et al. 2003 The prevention of radiocontrast-agent-induced nephropathy by hemofiltration New Engl J Med 349 1333 1340 14523141 1:CAS:528:DC%2BD3sXnvVGitL4%3D (Pubitemid 37186211)
124. CA Naughton 2008 Drug-induced nephrotoxicity Am Fam Physician 78 743 750 18819242
125. N Pannu MK Nadim 2008 An overview of drug-induced acute kidney injury Crit Care Med 36 4 Suppl S216 S223 18382197 1:CAS:528:DC%2BD1cXktVCksLY%3D
126. EK Fishman D Reddan 2008 What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography Acta Radiol 49 310 320 18365820 1:STN:280:DC%2BD1c3gvVKltw%3D%3D
127. D Reddan EK Fishman 2008 Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists Eur J Radiol 66 235 245 17728089 (Pubitemid 351626392)
128. C Briguori A Colombo F Airoldi, et al. 2006 Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures Catheter Cardiovasc Interv 67 175 180 16400668 (Pubitemid 43235147)
129. B Elmsthåhl U Nyman P Leander, et al. 2004 Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs Acad Radiol 11 1219 1228
130. CM Erley BD Bader ED Berger, et al. 2004 Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients Nephrol Dial Transplant 19 2526 2531 15280530 1:CAS:528: DC%2BD2cXnvVOltL4%3D (Pubitemid 39360099)
131. HS Thomsen T Almèn SK Morcos, et al. 2002 Gadolinium-containing contrast media for radiographic examinations: a position paper Eur Radiol 12 2600 2605 12271402 (Pubitemid 36940367)
132. TM Arsenault BF King JW Marsh Jr, et al. 1996 Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience Mayo Clin Proc 71 1150 1154 8945485 1:STN:280:DyaK2s7gtV2mug%3D%3D
133. HL Zhang H Ersoy MR Prince 2006 Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements J Magn Reson Imag 23 383 387 (Pubitemid 43364066)
134. U Hoffmann M Fischereder A Reil, et al. 2005 Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function Eur J Med Res 10 149 154 15946910 1:CAS:528:DC%2BD2MXmtFKhtrc%3D (Pubitemid 40584984)
135. MR Prince C Arnoldus JK Frisoli 1996 Nephrotoxicity of high-dose gadolinium compared with iodinated contrast J Magn Reson Imag 6 162 166 1:STN:280:DyaK2s%2FgsVWisw%3D%3D (Pubitemid 126702459)
136. B Tombach C Bremer P Reimer, et al. 2001 Renal tolerance of a neutral
137. AD Sam II MD Morasch J Collins, et al. 2003 Safety of gadolinium contrast angiography in patients with chronic renal insufficiency J Vasc Surg 38 313 318 12891113 (Pubitemid 41123255)
138. I Ergun K Keven I Uruc, et al. 2006 The safety of gadolinium in patients with stage 3 and 4 renal failure Nephrol Dial Transplant 21 697 700 16326736 (Pubitemid 43372917)
139. H Akgun G Gonlusen J Cartwright, et al. 2006 Are gadolinium-based contrast media nephrotoxic? A renal biopsy study Arch Pathol Lab Med 130 1354 1357 16948524 (Pubitemid 44373073)
140. HS Thomsen 2004 Gadolinium-based contrast media may be nephrotoxic even at approved doses Eur Radiol 14 1654 1656 15221265 (Pubitemid 39232897)
141. S Bolen L Feldman J Vassy, et al. 2007 Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes Ann Intern Med 147 386 399 17638715 (Pubitemid 351664540)
142. NICE Clinical Guideline. CG 87 Type 2 diabetes-newer agents (a partial update of CG 66): short guideline; Updated 18 June 2009 (2009) Available at http://www.nice.org.uk/nicemedia/live/12165/44320/44320.pdf Accessed 24 November 2010
143. CJ Bailey RC Turner 1996 Metformin New Engl J Med 334 574 579 8569826 1:CAS:528:DyaK28XhvVCjs74%3D (Pubitemid 126537875)
144. Electronic Medicines Compendium: Glucophage SR. Updated 25 August 2009 (2009) Available at http://www.medicines.org.uk/EMC/medicine/20952/SPC Accessed 24 November 2010
145. M Stang DK Wysowski D Butler-Jones 1999 Incidence of lactic acidosis in metformin users Diabetes Care 22 925 927 10372243 1:STN:280:DyaK1MzgtVygsw%3D%3D (Pubitemid 29241046)
146. Salpeter S, Greyber E, Pasternak G, Salpeter EE (2010) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev CD002967
147. DR Cryer SP Nicholas DH Henry, et al. 2005 Comparative outcomes study of metformin intervention versus conventional approach the COSMIC approach study Diabetes Care 28 539 543 15735184 1:CAS:528:DC%2BD2MXivVaisrw%3D (Pubitemid 40315310)
148. NC Sambol J Chiang ET Lin, et al. 1995 Kidney function and age are both predictors of pharmacokinetics of metformin J Clin Pharmacol 35 1094 1102 8626883 1:CAS:528:DyaK28XkslWguw%3D%3D
149. CR Sirtori C Pasik 1994 Re-evaluation of a biguanide, metformin: mechanism of action and tolerability Pharmacol Res 30 187 228 7862618 1:CAS:528:DyaK2MXivFajsb8%3D (Pubitemid 24365533)
150. Electronic Medicines Compendium: Glucophage. Updated 12 October 2010 (2010) Available at http://www.medicines.org.uk/EMC/medicine/1043/SPC Accessed 24 November 2010
151. A Holstein M Stumvoll 2005 Contraindications can damage your health-is metformin a case in point? Diabetologia 48 2454 2459 16283245 1:STN:280:DC%2BD2Mnjsl2rug%3D%3D (Pubitemid 41738207)
152. JS Shaw RL Wilmot ES Kilpatrick 2007 Establishing pragmatic estimated GFR thresholds to guide metformin prescribing Diabet Med 24 1160 1163 17672860 1:STN:280:DC%2BD2srmslSksQ%3D%3D (Pubitemid 47437878)
153. RE Warren MWJ Strachan S Wild JA McKnight 2007 Introducing glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin Diabet Med 24 494 497 17367305 1:CAS:528:DC%2BD2sXmvVeis7s%3D (Pubitemid 46669323)
154. PA McCullough F Stacul CR Becker, et al. 2006 Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary Rev Cardiovasc Med 7 177 197 17224862 (Pubitemid 46139115)
155. MR Rudnick S Goldfarb L Wexler, et al. 1995 Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomised trial Kidney Int 47 254 261 7731155 1:STN:280:DyaK2M3kvVKlsA%3D%3D
156. SK Goergen G Rumbold G Compton C Harris 2010 Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin Radiology 254 261 269 20032157
157. HS Thomsen SK Morcos T Almen, et al. 2010 Metformin and contrast media (Letter) Radiology 256 672 673 20656850
158. R Gupta 2002 Use of contrast agents in patients receiving metformin (Letter) Radiology 225 311 312 12355024
159. MA Bettman 2002 Use of intravenous contrast agents in patients receiving metformin (Letter) Radiology 225 312